BioCentury
ARTICLE | Company News

IBL Gesellschaft fuer Immunchemie und Immunbiologie mbH, Immuno-Biological Laboratories, Innogenetics sales and marketing update

January 1, 2007 8:00 AM UTC

INNX received exclusive worldwide rights to distribute Immuno-Biological's ELISA-based tests for identifying specific forms of the beta amyloid protein in Alzheimer's disease (AD). The deal excludes ...